Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Betamethasone

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44380   clinical trials with a EudraCT protocol, of which   7392   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    110 result(s) found for: Betamethasone. Displaying page 6 of 6.
    « Previous 1  2  3  4  5  6 
    EudraCT Number: 2007-000152-14 Sponsor Protocol Number: PHRN/06/LV-RALIB Start Date*: 2007-05-23
    Sponsor Name:CHRU-TOURS
    Full Title: Efficacité de la rapamycine topique dans le traitement des lichens érosifs chroniques de la muqueuse buccale:Etude en double aveugle randomisée rapamycine vs corticoïdes
    Medical condition: Patients atteints de lichen buccal érosif depuis plus de 6 semaines vus en consultation spécialisée dans des hôpitaux universitaires. Comparer l’effet de deux stratégies thérapeutiques, (1) rapamyc...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030983 Oral lichen planus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-005035-29 Sponsor Protocol Number: VAL-010 Start Date*: 2007-11-12
    Sponsor Name:Valderm ApS
    Full Title: A 13 day placebo- and reference-controlled, double-blind, monocentric, randomized, intraindividual comparative clinical phase IIa study, investigating the efficacy and tolerability of valrubicin cr...
    Medical condition: Mild to Moderate Plaque Psoriasis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037153 Psoriasis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-001189-14 Sponsor Protocol Number: PQR309-401 Start Date*: 2019-11-08
    Sponsor Name:PIQUR Therapeutics AG
    Full Title: Exploratory study of the efficacy and safety of topical bimiralisib in an inflammatory and hyperproliferative skin condition
    Medical condition: inflammatory and hyperproliferative skin condition
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2011-004953-17 Sponsor Protocol Number: TUD-OCTpro-053 Start Date*: 2012-05-25
    Sponsor Name:Technical university Dresden
    Full Title: Measurement of epidermal and dermal thickness under therapy with Pimecrolimus 1 % Creme (Elidel® 1 % Creme), Hydrocortisonacetat 1 % Creme (Hydrogalen® Creme), Betamethasonvalerat 0,1 % Creme (Bet...
    Medical condition: - age 18-40 years - health volunteers - normal dermis - written accordance of the test person
    Disease: Version SOC Term Classification Code Term Level
    14.0 10042613 - Surgical and medical procedures 10071104 Glucocorticoid therapy LLT
    14.0 10028395 - Musculoskeletal and connective tissue disorders 10068183 Calcineurin inhibitor induced pain syndrome LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-010759-29 Sponsor Protocol Number: 001 Start Date*: 2009-04-27
    Sponsor Name:Cliniques Universitaires Saint-Luc
    Full Title: étude clinique sur l’administration de 3 doses de betaméthasone (12mg) à 18 heures d’intervalle lors d’une menace d’accouchement prématuré dans les grossesses gémellaires traitées par Atosiban, plu...
    Medical condition: Premature delivery in twin pregnancies
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036564 Pregnancy multiple LLT
    9.1 10028244 Multiple pregnancy affecting fetus or newborn LLT
    Population Age: In utero, Under 18, Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2007-002913-38 Sponsor Protocol Number: DIPROCOL-0707 Start Date*: 2007-07-20
    Sponsor Name:Centre Oscar Lambret
    Full Title: Essai de phase II multicentrique sur le traitement préventif de la folliculite induite par les anti-EGFR chez des patients atteints de cancer colorectal métastatique sous Cetuximab ou atteints de c...
    Medical condition: Cancer colorectal métastatique exprimant l’EGFR et cancer bronchique non à petites cellules localement avancé ou métastatique, exprimant l’EGFR
    Disease: Version SOC Term Classification Code Term Level
    9.1 10025044 Lung cancer LLT
    9.1 10052362 Metastatic colorectal cancer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: View results
    EudraCT Number: 2011-000069-11 Sponsor Protocol Number: ECTEFABE Start Date*: 2011-07-29
    Sponsor Name:FERNADO PEREZ RUIZ
    Full Title: ENSAYO CLINICO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, DE GRUPOS PARALELOS,, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE TETRACOSÁCTIDO FRENTE A FOSFATO-ACETATO DE BETAMETASONA Y FRENTE A LA COMBINAC...
    Medical condition: El objetivo es demostrar la equivalencia terapéutica del Tetracosáctida en dosis única frente a Betametasona en dosis única. También son objetivos del ensayo demostrar la superioridad de la combina...
    Disease: Version SOC Term Classification Code Term Level
    14.0 10027433 - Metabolism and nutrition disorders 10003435 Articular gout LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Temporarily Halted)
    Trial results: (No results available)
    EudraCT Number: 2008-002795-96 Sponsor Protocol Number: CBFH772A2201 Start Date*: 2008-12-11
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A single center, phase I, partially blinded, placebo-controlled, first-in-man study to evaluate the safety, tolerability and Proof of Mechanism (PoM) of a single administration of BFH772 in healthy...
    Medical condition: Plaque psoriasis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037153 Psoriasis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2011-001557-85 Sponsor Protocol Number: 5.0 Start Date*: 2011-08-22
    Sponsor Name:Nordic Lymphoma Group
    Full Title: NLG-MCL5 (MARiT) Rituximab, High Dose Ara-C and Dexamethasone Followed by BEAM in Mantle Cell Lymphoma Patients <66 years A Nordic Lymphoma Group and British Lymphoma Group Phase-II Trial
    Medical condition: Mantle cell lymphoma
    Disease: Version SOC Term Classification Code Term Level
    13.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10026799 Mantle cell lymphoma NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Temporarily Halted) DK (Prematurely Ended) FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-022395-31 Sponsor Protocol Number: AC-004-EU Start Date*: 2010-10-07
    Sponsor Name:E.M.N. - EUROPEAN MYELOMA NETWORK
    Full Title: A randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for untreated patients with systemic light-chain (AL...
    Medical condition: AL amyloidosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10035227 HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed) SE (Ongoing) DK (Completed) GB (GB - no longer in EU/EEA) GR (Ongoing) ES (Ongoing) DE (Completed) CZ (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6 
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Feb 12 13:05:19 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA